Sharma East India Hosp and Medical Research Ltd
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]
- Market Cap ₹ 25.0 Cr.
- Current Price ₹ 76.2
- High / Low ₹ 142 / 22.5
- Stock P/E 20.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 13.7 %
- ROE 10.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 30.4 days to 16.0 days
Cons
- Company has a low return on equity of -6.97% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
12.50 | 16.36 | 17.21 | 17.14 | 16.00 | 14.73 | 16.17 | 8.13 | 17.04 | 20.73 | 18.52 | 29.87 | |
11.31 | 15.11 | 16.33 | 15.51 | 14.54 | 14.09 | 14.24 | 8.79 | 14.79 | 17.43 | 20.40 | 26.21 | |
Operating Profit | 1.19 | 1.25 | 0.88 | 1.63 | 1.46 | 0.64 | 1.93 | -0.66 | 2.25 | 3.30 | -1.88 | 3.66 |
OPM % | 9.52% | 7.64% | 5.11% | 9.51% | 9.12% | 4.34% | 11.94% | -8.12% | 13.20% | 15.92% | -10.15% | 12.25% |
1.04 | 0.55 | 0.22 | 0.26 | 0.07 | 1.11 | 0.03 | 2.83 | 0.06 | 0.06 | 5.31 | 0.31 | |
Interest | 0.59 | 0.76 | 0.48 | 1.08 | 0.73 | 0.88 | 1.15 | 0.69 | 0.70 | 1.18 | 0.95 | 0.72 |
Depreciation | 0.60 | 0.61 | 0.59 | 0.70 | 0.62 | 0.52 | 0.43 | 0.65 | 0.78 | 1.39 | 1.48 | 1.84 |
Profit before tax | 1.04 | 0.43 | 0.03 | 0.11 | 0.18 | 0.35 | 0.38 | 0.83 | 0.83 | 0.79 | 1.00 | 1.41 |
Tax % | 30.77% | -30.23% | 33.33% | 27.27% | 27.78% | 22.86% | 18.42% | 24.10% | 18.07% | -5.06% | 34.00% | 12.06% |
0.72 | 0.57 | 0.03 | 0.08 | 0.13 | 0.27 | 0.31 | 0.64 | 0.68 | 0.83 | 0.66 | 1.24 | |
EPS in Rs | ||||||||||||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 13% |
3 Years: | 21% |
TTM: | 61% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | 32% |
3 Years: | 22% |
TTM: | 128% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | -4% |
5 Years: | -7% |
3 Years: | -7% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 |
Reserves | 2.43 | 2.03 | 2.05 | 3.32 | 3.46 | 3.73 | 4.12 | 4.76 | 5.44 | 6.41 | 7.07 | 8.32 |
7.89 | 5.97 | 6.47 | 7.51 | 5.38 | 10.89 | 7.42 | 5.98 | 4.35 | 8.30 | 5.04 | 2.26 | |
1.90 | 2.36 | 2.68 | 2.65 | 3.28 | 3.35 | 4.16 | 3.98 | 5.11 | 4.84 | 8.89 | 12.93 | |
Total Liabilities | 16.38 | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.67 |
7.65 | 6.58 | 6.01 | 6.40 | 6.07 | 4.73 | 4.41 | 5.51 | 6.85 | 9.10 | 7.70 | 9.37 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.35 | 1.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.79 | 0.31 | 0.31 | 1.79 | 1.79 | 1.80 | 1.89 | 1.89 | 1.89 | 2.05 | 2.05 | 2.05 |
7.94 | 7.63 | 9.04 | 9.45 | 8.41 | 15.25 | 11.82 | 11.48 | 10.32 | 12.56 | 15.41 | 16.25 | |
Total Assets | 16.38 | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.67 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.40 | -0.20 | -0.14 | 0.82 | 3.12 | -1.43 | 1.21 | 1.40 | 2.03 | 1.28 | -1.13 | 6.69 | |
-0.57 | -0.02 | -0.01 | -0.77 | -0.25 | 1.65 | -1.50 | 2.79 | -2.11 | -3.63 | 5.17 | -3.26 | |
-0.80 | -0.81 | 0.19 | -0.08 | -2.80 | 4.74 | -4.74 | -2.16 | -1.78 | 2.77 | -4.20 | -3.50 | |
Net Cash Flow | 0.03 | -1.03 | 0.05 | -0.03 | 0.06 | 4.96 | -5.03 | 2.03 | -1.86 | 0.41 | -0.17 | -0.06 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 32.70 | 46.63 | 57.69 | 49.40 | 74.14 | 85.49 | 107.22 | 120.32 | 72.61 | 75.54 | 50.85 | 79.92 |
Inventory Days | 26.55 | 16.83 | 73.23 | 98.98 | 217.45 | 49.38 | 41.71 | 49.34 | 120.03 | |||
Days Payable | 170.33 | 138.49 | 120.54 | 143.83 | 481.49 | 390.76 | 304.84 | 362.82 | 237.78 | |||
Cash Conversion Cycle | -111.08 | -75.04 | 10.37 | 49.40 | 29.29 | 85.49 | 107.22 | -143.72 | -268.77 | -187.59 | -262.63 | -37.84 |
Working Capital Days | -35.04 | 100.40 | 120.25 | 135.86 | 112.69 | 170.98 | 166.13 | 231.66 | 100.67 | 114.80 | -39.61 | 16.01 |
ROCE % | 11.45% | 8.93% | 4.11% | 8.60% | 6.50% | 1.57% | 8.87% | -8.30% | 10.61% | 12.00% | -18.61% | 13.74% |
Documents
Announcements
-
Board Meeting Outcome for Approval Of Audited Financial Results For The Year Ended March 31 2025
14h - Approved audited standalone financial results for year ended March 31, 2025, with unmodified audit opinion.
- Approval Of Standalone Audited Financial Results Quarter And Year Ended On 31St March, 2025 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement, 2015 13h
-
Board Meeting Intimation for Approval Of Standalone Audited Financial Results For The Quarter And Year Ended March 31 2025.
15 May - Board meeting on May 23 to approve FY25 audited financial results; trading window closed till results release.
-
Intimation Of Appointment Of Internal Auditor And Secretarial Auditor Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
9 May - Appointment of internal and secretarial auditors for FY 2025-26 by Sharma East India Hospitals.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On May 9 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Appointment Of Internal Auditor And Secretarail Auditor
9 May - Appointed Jain Vaibhav & Associates as Internal Auditor and HSPN & Associates LLP as Secretarial Auditor for FY 2025-26.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
SEIHMR is provides medical & healthcare services. It runs a NABH accredited multi specialty hospital viz. Jaipur Hospital at Lal Kothi, Tonk Road, Jaipur.